Doxycycline: Clinical Trials

61 trials of Doxycycline, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

39 completed, 11 unknown, 3 not yet recruiting, 3 recruiting. 61 Phase 3, 11 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 361Completed 39, Unknown 11, Not yet recruiting 3, Recruiting 3, Withdrawn 3, Terminated 2
Phase 211Completed 4, Unknown 3, Recruiting 2, Not yet recruiting 1, Terminated 1

Follow Doxycycline: new trials by email Literature Review of Doxycycline trials Research Report on Doxycycline

Trials (filtered) newest first · largest first

All 61 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Study to Assess the Efficacy of Weekly Doxycycline Prophylaxis to Reduce Bacterial Sexually Transmitted Infections (STI) in Young African Women
Doxycycline hyclate, Standard of Care for STI prevention - Sexually Transmitted Infection (STI), Gonorrhea
Phase 3Not yet recruitingNational Institute of Allergy and Infectious Diseases (NIAID)5802026-11-302026-10-20
AUTOP 2: Screen-and-treat Strategy for Vaginal Flora Abnormalities by Molecular Biology in Pregnant Women at High Risk of Preterm Birth
Vaginal flora abnormalities screening and quantification using molecular biology technique, Azithromycin, Ceftriaxone - Bacterial Vaginosis, Vaginal Dysbiosis
Phase 3Not yet recruitingAssistance Publique Hopitaux De Marseille17942026-10-012026-08-27
Rickettsia Clearance Study
Doxycyclin, Azithromycin - Infectious Disease, Therapeutics
Phase 2 / Phase 3RecruitingLao-Oxford-Mahosot Hospital Wellcome Trust Research Unit722024-11-012026-10-13
Combination Therapy Between Doxycycline, Pentoxifylline, and Nitazoxanide in Sexually Active Men
Doxycyclin, Pentoxifylline, Nitazoxanide 500Mg Oral Tablet - Sexually Transmitted Diseases
Phase 2 / Phase 3Not yet recruitingTanta University1002023-06-202023-06-12
Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis
Doxycycline, Placebo - Tuberculosis, Acute Coronary Syndrome
Phase 3RecruitingNational University Hospital, Singapore1502023-05-242026-06-09
Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer
Metabolic treatment - Cancer, Overall Survival
Phase 3WithdrawnHealth Clinics Limited2022-05-232022-07-18
Efficacy of Azithromycin Plus Doxycycline Versus Doxycycline Plus Placebo in Patients With Rocky Mountain Spotted Fever
Azithromycin + Doxycycline, Placebo + Doxycycline - Rocky Mountain Spotted Fever
Phase 3UnknownHospital General de Mexicali862022-05-122022-05-31
A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2)
DFD-29, Doxycycline, Placebo - Papulopustular Rosacea
Phase 3CompletedJourney Medical Corporation3302022-03-292024-12-03
A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea.
DFD-29, Doxycycline, Placebo - Papulopustular Rosacea
Phase 3CompletedJourney Medical Corporation3232022-03-142024-12-03
Intralesional Voriconazole, or Intralesional Cryotherapy, or Oral Doxycycline in the Treatment of Cutaneous Leishmaniasis
Intralesional Sodium stibogluconate, Intralesional Cryotherapy, Intralesional Voriconazole - Leishmaniasis, Cutaneous
Phase 3UnknownZagazig University1362022-01-012023-08-29
Clinical Trial of Doxycycline VS BPG for Early Syphilis (SY-DOXY)
BPG, Doxycycline - Syphilis
Phase 3CompletedAssistance Publique - Hôpitaux de Paris2002021-12-062025-11-20
Role of Doxycycline in Chronic Rhinosinusitis With Nasal Polyps
Doxycycline 100 mg Oral Tablet, Prednisolone 20 mg - Nasal Polyps, Chronic Rhinosinusitis With Nasal Polyps
Phase 3CompletedAssiut University602021-07-012024-08-13
DYNAMIC Study (DoxycYcliNe AMbulatoIre COVID-19)
Doxycycline, Placebo - COVID19
Phase 3WithdrawnNantes University Hospital2021-02-012022-04-20
OD-doxy-PNV-COVID-19 Old Drug " DOXY " for Prevention of New Virus " COVID-19 "
Doxycyclin - Covid19
Phase 3CompletedHedi Gharsallah1942020-11-202021-11-19
Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection
Ivermectin and Doxycycline, Standard of care - Covid19
Phase 3CompletedDhaka Medical College4002020-06-012020-10-09
Evaluation of the Efficacy and Safety of Treatments for Patients Hospitalized for COVID-19 Infection Without Signs of Acute Respiratory Failure, in Tunisia
HCQ, Azithromycin, Doxycycline - COVID 19, Patients Hospitalized
Phase 3WithdrawnAbderrahmane Mami Hospital2020-05-152020-08-27
The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol
Hydroxychloroquine, Azithromycin, Hydroxychloroquine, Doxycycline, Hydroxychloroquine, Clindamycin - CoVid 19 Positive
Phase 2 / Phase 3CompletedThe Camelot Foundation18002020-04-112020-11-12
Finding the Optimal Regimen for Mycobacterium Abscessus Treatment
Amikacin, Tigecycline, Imipenem - Pulmonary Disease Due to Mycobacteria (Diagnosis)
Phase 2 / Phase 3RecruitingThe University of Queensland3002020-03-022026-05-11
Prospective Evaluation of Oral Antibiotics for Treatment of Shoulder PJI
Doxycycline 100 MG Oral Tablet - Periprosthetic Infection, Oral Antibiotics
Phase 3UnknownRothman Institute Orthopaedics1002019-09-242020-11-19
Effect of Doxycycline on Cardiac Remodelling in STEMI Patients
Doxycycline 100Mg Capsule, Placebo oral capsule - ST Elevation Myocardial Infarction, Anterior Wall Myocardial Infarction
Phase 3UnknownFelix Chikita Fredy, MD802019-05-252019-08-06

Showing 20 of 61. Sign in to see all of them.

Conditions studied

Acne Vulgaris (4)  ·  COVID-19 (4)  ·  Chlamydia Infections (4)  ·  Rosacea (4)  ·  Elephantiasis, Filarial (3)  ·  Filariasis (3)  ·  Lymphedema (3)  ·  Syphilis (3)  ·  Alzheimer Disease (2)  ·  Chronic Periodontitis (2)  ·  Disease (2)  ·  Inflammation (2)  ·  Lyme Disease (2)  ·  Lyme Neuroborreliosis (2)  ·  Neoplasm Metastasis (2)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (5)  ·  The Task Force for Global Health (3)  ·  CollaGenex Pharmaceuticals (2)  ·  Fondazione IRCCS Policlinico San Matteo di Pavia (2)  ·  Galderma R&D (2)  ·  Journey Medical Corporation (2)  ·  Nantes University Hospital (2)  ·  Sorlandet Hospital HF (2)  ·  Tanta University (2)  ·  Abderrahmane Mami Hospital (1)  ·  Amirhossein Farahmand (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Assistance Publique Hopitaux De Marseille (1)  ·  Assiut University (1)  ·  CD Pharma India Pvt. Ltd. (1)

Countries

United States (20)  ·  Canada (6)  ·  United Kingdom (5)  ·  Egypt (4)  ·  France (4)  ·  Germany (2)  ·  India (2)  ·  Italy (2)  ·  Puerto Rico (2)  ·  Singapore (2)  ·  Tunisia (2)  ·  Australia (1)  ·  Bangladesh (1)  ·  Botswana (1)  ·  China (1)

Top investigators

Eric Ottesen, MD (3)  ·  Srinivas R Sidgiddi, M.D. (2)  ·  Alwin Cunje, MD, PhD (1)  ·  Aly Ragaie (1)  ·  Anne Marit Solheim, M.D (1)  ·  Arun Sadasivan, MDS (1)  ·  Arya K.S., BDS (1)  ·  Bambang Widyantoro, PhD (1)  ·  Batikh R Riadh, physican (1)  ·  Brandon M Kucher, PhD (1)  ·  Brandon M Kucher, PhD, MD (1)  ·  Catherine Ong, MRCP PhD (1)  ·  D.William Molloy, MB, MRCPI, FRCPC (1)  ·  Dan Liang, MD (1)

Results publications

PMID 11873261, PMID 22610930, PMID 32228663, PMID 10656038, PMID 40042869, PMID 17668979, PMID 17716312, PMID 17716313, PMID 18567539, PMID 18672990, PMID 20151804, PMID 20155838, PMID 20348487, PMID 20402591, PMID 20937388, PMID 21357860, PMID 21422479, PMID 21998287, PMID 22325113, PMID 22431798, PMID 23071896, PMID 23205917, PMID 23223595, PMID 23649042, PMID 24106340, PMID 24934963, PMID 25616607, PMID 26179246, PMID 26699167, PMID 31526286, PMID 32164673, PMID 32586344, PMID 32632956, PMID 33974018, PMID 33983065, PMID 37450935, PMID 38030064, PMID 38380975, PMID 38914204, PMID 39362220, PMID 41121745

NIH funding

2015 (1), 2019 (1), 2023 (1), R01AI072728 (1), R01AR043348 (1), R01DE012872 (1), R21AR053646 (1), U01HL128954 (1), U19AI031448 (1)